Sustainable Growth Advisers 13F: Cuts COO Stake by $26M

Sustainable Growth Advisers trimmed its investment in The Cooper Companies, Inc. (NasdaqGS: COO), cutting its stake by 23.4% according to a Form 13F filing with the Securities and Exchange Commission on October 15, 2026. Institutional holdings reports are backward-looking and reflect positions held at the close of the reporting period, meaning this filing may not represent the fund's current holdings today.

Inside Sustainable Growth Advisers's The Cooper Companies Trade

The fund parted ways with 455,540 shares of the medical technology firm during the period. That left Sustainable Growth Advisers with 1,492,568 shares. The remaining stake had a reported value of $84,374,869.00 when the filing was processed.

Other Institutional Activity in The Cooper Companies

Other large funds also adjusted their portfolios around the same time. Blackrock Inc. reduced its holdings by 1,588,695 shares, ending with 15,029,453 shares worth about $870,806,486.00. Vanguard Capital Management LLC grew its holdings by 39,430 shares, ending with 12,758,769 shares worth about $739,243,058.00. State Street Corporation grew its holdings by 124,508 shares, ending with 8,892,643 shares worth about $515,239,723.00. Vanguard Portfolio Management LLC reduced its holdings by 51,455 shares, ending with 8,669,690 shares worth about $502,321,826.00. T. Rowe Price Investment Management, Inc. reduced its holdings by 1,630,874 shares, ending with 7,429,535 shares worth about $430,467,247.00.

The Cooper Companies, Inc. Stock Up 0.6%

The Cooper Companies shares recently traded around $57.72 as of October 16, 2026. The stock has moved within a 52-week range of $51.01 to $89.83.

Recent Earnings

The company reported trailing-twelve-month revenue of $4,236,900,096.00 and basic earnings per share of $2.91. The next earnings report is scheduled for December 10, 2026.

Insider Buying and Selling at The Cooper Companies, Inc.

Company insiders were active in the market prior to the filing. On September 11, 2026, Director Paul A Keel bought 4,701 shares at an average price of $53.18, totaling $250,000.00. On September 14, 2026, Director Walter M Rosebrough Jr bought 10,000 shares valued at $541,640.00. On September 14, 2026, Director Lawrence Erik Kurzius bought 10,000 shares at an average price of $53.92, totaling $539,150.00. Later, on September 16, 2026, Director Lawrence Erik Kurzius bought another 10,000 shares at an average price of $54.93, totaling $549,320.00.

Analysts Set New Price Targets

Wall Street firms updated their views on the stock ahead of the filing. On September 10, 2026, William Blair downgraded the stock with a Market Perform rating. On September 10, 2026, Wells Fargo maintained an Equal-Weight rating and lowered its price target to $61.00 from $66.00. On September 11, 2026, Mizuho maintained an Outperform rating and lowered its price target to $75.00 from $85.00. On September 15, 2026, Needham reiterated a Buy rating with a $73.00 price target. On October 7, 2026, Barclays initiated coverage with an Equal-Weight rating and a $60.00 price target. Across the broader analyst community, the stock carries a consensus hold rating and an average price target of $65.80.

About The Cooper Companies

Based in San Ramon, California, The Cooper Companies operates in the healthcare sector through its CooperVision and CooperSurgical segments, manufacturing contact lenses and medical devices that address vision challenges like astigmatism and presbyopia.

Bottom Line

Investors tracking Sustainable Growth Advisers will want to watch for subsequent 13F filings to see if the fund continues trimming its exposure to medical technology names. The company's upcoming earnings release on December 10, 2026, will offer fresh insight into its financial trajectory.